NAMSA Sponsoring Conference on Best Practices for Biocompatibility and Performance of Medical Devices

NORTHWOOD, Ohio, Jan. 8, 2013 /PRNewswire/ -- NAMSA, the world's leading medical device research organization, is sponsoring a comprehensive symposium based on the definitive new book, "Biocompatibility and Performance of Medical Devices," assembled by ANSM expert Dr. Jean-Pierre Boutrand, in London, England, February 12-14. This one-of-a-kind event offers attendees crucial insights on medical device testing.

The two-day symposium is a unique gathering of international thought leaders representing a diverse mix of professionals in research and development, quality assurance, regulatory affairs and product engineering, and is designed for professionals in these and other device-related positions.

"Implant and device manufacturers are increasingly facing the challenge of proving their products are safe, biocompatible and will perform as expected," said Dr. Boutrand. "This event will prove an essential guide to the performance analysis of medical devices and will feature expertise for every medical specialty – from cardiology to bone healing, tissue engineering to combined products."

Attendees will hear from multiple members of the international team who co-authored the book on critical topics such as biocompatibility evaluation and overcoming negative test results in manufacture. Event speakers include:

Dr. Jean-Pierre Boutrand, NAMSA
Professor David F. Williams, Wake Forest Institute of Regenerative Medicine
Dr. Kelly Coleman, Medtronic, Inc.
Dr. David Albert, NAMSA
Dr. Ronald Brown, U.S. Food and Drug Administration
Dr. Joseph Carraway, NAMSA
Michael F. Wolf, Medtronic, Inc.
Dr. David Parente, Ecolab
Dr. Roy Martin, NAMSA
Dr. Andrew Lewis, Biocompatibles UK Ltd
Dr. Adrian Keene, SGS
An Liu, NAMSA
Professor Jiao Sun, Shanghai Biomaterials Research & Testing Center, Shanghai Jiaotong University

"NAMSA's thrilled to support this rare gathering of international thought leaders sharing insights on vital topics affecting our industry," said Terry Langenderfer, NAMSA's director or global marketing. "Attendees will learn more about the best options, techniques and methods for proving biocompatibility and performance of medical devices from those who have succeeded in these areas."

A second symposium will be held in Minneapolis, Minn., USA, May 14-16. For more information on this international event, visit www.bpmds2013.com and follow event updates on Twitter at www.twitter.com/MedDeviceTests.

About NAMSA
NAMSA (www.namsa.com) is a global medical device research organization providing a
comprehensive range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. For more than 45 years, NAMSA clients have utilized its testing and consulting services to bring safe and effective therapies to market.

Contact Information
For further information about NAMSA, contact:
Sean Hamilton
Marketing Communications Manager
419.662.4846
[email protected]

SOURCE NAMSA